During the past decade, Summit Medical Group conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 11 clinical trials were completed, i.e. on average, 26.8% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 10 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Summit Medical Group" #1 sponsor was "BeiGene" with 4 trials, followed by "Incyte Corporation" with 4 trials sponsored, "Seagen Inc." with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Summit Medical Group" #1 collaborator was "Merck Sharp & Dohme LLC" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Summit Medical Group" are "Chronic Lymphocytic Leukemia" (3 trials), "Diffuse Large B-cell Lymphoma" (2 trials), "Follicular Lymphoma" (2 trials), "Lung Cancer" (2 trials) and "Small Lymphocytic Lymphoma" (2 trials). Many other conditions were trialed in "Summit Medical Group" in a lesser frequency.

Most popular intervention types in "Summit Medical Group" are "Drug" (41 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Docetaxel" (6 trials), "Pembrolizumab" (5 trials), "Placebo" (5 trials), "Gemcitabine" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Summit Medical Group" are 40 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Summit Medical Group". undefined are not yet recruiting, 17 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Summit Medical Group, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Summit Medical Group, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".

Summit Medical Group has several departments that took part in Clinical trials: "Summit Medical Group Overlook Oncology Center" - 4 trials, "Summit Medical Group Cancer Center" - 2 trials